• 10% increase in recurring revenue to $13.5M
• Achieved break-even operating profit of $0.1M
• Positive operating cash flow of $0.4M, with $4.3M in undrawn debt facility

Beamtree Holdings Ltd (ASX:BMT) has reported its 1H FY26 financial results, highlighting strong performance across key metrics. The company recorded a 10% increase in recurring revenue to $13.5M, driven by growth across its product segments, including Diagnostic (8% growth), Coding & Data Quality Assurance (21% growth), and Knowledge Networks (8% growth). Total revenue grew by 2% to $14.5M. Beamtree achieved break-even operating profit of $0.1M, a significant improvement from the prior corresponding period, despite continued investment in strategic priorities and geographical expansion, including $2M in Evolve, the company's next-generation analytics and benchmarking platform for the UK NHS. The company generated positive operating cash flow of $0.4M, supported by effective working capital management. Beamtree maintains a strong liquidity position, with $2.9M in cash on hand and access to a further $4.3M via an undrawn debt facility. The company's net current assets stood at $4.6M as of 30 June 2025. Beamtree's Annual Recurring Revenue (ARR) stood at $28.0M as of February 2026, up 10% from the prior corresponding period, with $27.2M in contracted revenue and $0.8M in verbal commitments. The company is targeting accelerated double-digit ARR growth for FY26 and is committed to becoming self-funded in the near term.

Beamtree is targeting accelerated double-digit ARR growth for FY26.

Beamtree's board has initiated a strategic review to examine operational priorities and corporate options, including strategic partnerships. The company is committed to executing its strategy and accelerating revenue growth, leveraging its strong team and defined market opportunity with strong partners. Ongoing product innovation, including the use of AI, is also a focus for the company.